Sidley Austin is representing Nektar Therapeutics in the transaction, and Goodwin Procter is representing Ampersand Capital Partners. Ampersand has agreed to acquire Nektar’s commercial-scale manufacturing facility...
Ampersand’s Acquisition of a Nektar’s Manufacturing Facility and Reagent Supply Business
Charlesbank Capital Partners’ Growth Investment in MB2 Dental
Goodwin Procter LLP advised Charlesbank Capital Partners on the deal. Charlesbank Capital Partners, a middle-market private investment firm, announced that an affiliated fund has made a significant...